Abstract
To study genetic alterations related to the development and/or progression of breast carcinoma, we examined amplification of the ERBB2, INT2, and MYC genes, as well as loss of heterozygosity (LOH) at loci on 11p, 16q, 17p (D17S5 and TP53), 17q (D17S74 and NME1), and 18q by restriction fragment length polymorphism analysis. The subjects were 26 patients with small breast carcinomas (≦2 cm) and 88 patients with larger breast carcinomas (2 to < 5 cm). All patients were free of distant metastasis. As tumor diameter increased, the frequency of oncogene amplification and LOH at all loci except D17S5 increased. However, there was no relationship between tumor diameter and amplification of specific oncogenes or allelic loss at specific loci. LOH at D17S5 was detected in 40% of small breast carcinomas (≦2 cm) and 43% of larger breast carcinomas (2 to < 5 cm). There was a significant correlation of LOH at D17S5 with INT2 amplification or with LOH on 11p, 16q, and 18q. These findings suggest that LOH at D17S5 may be involved in the early stage of breast carcinoma development, while INT2 amplification and LOH at 11p, 16q, and 18q appear to be genetic alterations that occur with tumor progression. In addition, as lymph node metastases were significantly related to amplification of the ERBB2 and MYC genes, and LOH of the NME1 gene, these genetic alterations may play a role in the mechanism of lymph node metastases.
Keywords: Breast carcinoma, Oncogene amplification, Restriction fragment length polymorphism analysis, Loss of heterozygosity
Full Text
The Full Text of this article is available as a PDF (350.4 KB).
REFERENCES
- 1. ) Slamon , D. J. , Clark , G. M. , Wong , S. G. , Levin , W. J. , Ullrich , A. and McGuire , W. L.Human breast cancer: correlation of relapse and survival with amplification of the HER‐2/neu oncogene . Science , 235 , 177 – 182 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Lidereau , R. , Callahan , R. , Dickson , C. , Peters , G. , Escot , C. and Ali , I. U.Amplification of the int‐2 gene in primary human breast tumors . Oncogene Res. , 2 , 285 – 291 ( 1988. ). [PubMed] [Google Scholar]
- 3. ) Escot , C. , Theillet , C. , Lidereau , R. , Spyratos , F. , Champeme , M‐H. , Gest , J. and Callahan , R.Genetic alteration of the c‐myc proto‐oncogene (MFC) in human primary breast carcinomas . Proc. Natl. Acad. Sci. USA , 83 , 4834 – 4838 ( 1986. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. ) Callahan , R. , Cropp , C. S. , Merlo , G. R. , Liscia , D. S. , Cappa , A. P. M. and Lidereau , R.Somatic mutations and human breast cancer . Cancer , 69 , 1582 – 1588 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Vogelstein , B. , Fearon , E. R. , Hamilton , S. R. , Kern , S. E. , Preisinger , A. C. , Leppert , M. , Nakamura , Y. , White , R. , Smits , A. M. M. and Bos , J. L.Genetic alterations during colorectal‐tumor development . N. Engl. J. Med. , 319 , 525 – 532 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Japanese Breast Cancer Society . The general rules for clinical and pathological recording of breast cancer . Jpn. J. Surg. , 19 , 612 – 632 ( 1989. ) ( in Japanese ). [DOI] [PubMed] [Google Scholar]
- 7. ) Watatani , M. , Perantoni , A. O. , Reed , C. D. , Enomoto , T. , Wenk , M. L. and Rice , J. M.Infrequent activation of K‐ras, H‐ras, and other oncogenes in hepatocellular neoplasms initiated by methyl(acetoxymethyl)nitrosamine, a methylating agent, and promoted by phenobarbital in F344 rats . Cancer Res. , 49 , 1103 – 1109 ( 1989. ). [PubMed] [Google Scholar]
- 8. ) Southern , E. M.Detection of specific sequences among DNA fragments separated by gel electrophoresis . J. Mol. Biol. , 98 , 503 – 517 ( 1975. ). [DOI] [PubMed] [Google Scholar]
- 9. ) Clark , G. M. and McGuire , W. L.Follow‐up study of HER‐2/neu amplification in primary breast cancer . Cancer Res. , 51 , 944 – 948 ( 1991. ). [PubMed] [Google Scholar]
- 10. ) Callahan , R. and Campbell , G.Mutations in human breast cancer: an overview . J. Natl. Cancer Inst. , 81 , 1780 – 1786 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Garcia , I. , Dietrich , P‐Y. , Aapro , M. , Vauthier , G. , Vadas , L. and Engel , E.Genetic alterations of c‐myc, c‐erbB‐2, and c‐Ha‐ras protooncogenes and clinical associations in human breast carcinomas . Cancer Res. , 49 , 6675 – 6679 ( 1989. ). [PubMed] [Google Scholar]
- 12. ) Maeda , S. , Watatani , M. , Nagayama , K. , Kadota , K. , Ozaki , K. , Wada , T. and Yasutomi , M.Immunohistochemical analysis of overexpression of c‐erbB‐2 protein in node‐positive breast carcinoma . J. Jpn. Surg. Soc. , 94 , 86 – 92 ( 1993. ) ( in Japanese ). [PubMed] [Google Scholar]
- 13. ) Borg , A. , Tandon , A. K. , Sigurdsson , H. , Clark , G. M. , Ferno , M. , Fuqua , S. A. W. , Killander , D. and McGuire , W. L.HER‐2/neu amplification predicts poor survival in node‐positive breast cancer . Cancer Res. , 50 , 4332 – 4337 ( 1990. ). [PubMed] [Google Scholar]
- 14. ) Nigro , J. M. , Baker , S. J. , Preisinger , A. C. , Jessup , J. M. , Hostetter , R. , Cleary , K. , Bigner , S. H. , Davidson , N. , Baylin , S. , Devilee , P. , Glover , T. , Collins , F. S. , Weston , A. , Modali , R. , Harris , C. C. and Vogelstein , B.Mutations in the p53 gene occur in diverse human tumor types . Nature , 342 , 705 – 708 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Malkin , D. , Li , F. P. , Strong , L. C. , Fraumeni , J. F. , Nelson , C. E. , Kim , D. H. , Kassel , J. , Gryka , M. A. , Bischoff , F. Z. , Tainsky , M. A. and Friend , S. H.Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms . Science , 250 , 1233 – 1238 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 16. ) Coles , C. , Thompson , A. M. , Elder , P. A. , Cohen , B. B. , Mackenzie , I. M. , Cranston , G. , Chetty , U. , Mackay , J. , Macdonald , M. , Nakamura , Y. , Hoyheim , B. and Steel , C. M.Evidence implicating at least two genes on chromosome 17p in breast carcinogenesis . Lancet , 336 , 761 – 763 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 17. ) Sato , T. , Akiyama , F. , Sakamoto , G. , Kasumi , F. and Nakamura , Y.Accumulation of genetic alterations and progression of primary breast cancer . Cancer Res. , 51 , 5794 – 5799 ( 1991. ). [PubMed] [Google Scholar]
- 18. ) Davidoff , A. M. , Humphrey , P. A. , Iglehart , J. D. and Marks , J. R.Genetic basis for p53 overexpression in human breast cancer . Proc. Natl. Acad. Sci. USA , 88 , 5006 – 5010 ( 1991. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. ) Davidoff , A. M. , Kerns , B‐J. M. , Iglehart , J. D. and Marks , J. R.Maintenance of p53 alterations throughout breast cancer progression . Cancer Res. , 51 , 2605 – 2610 ( 1991. ). [PubMed] [Google Scholar]
- 20. ) Sato , T. , Tanigami , A. , Yamakawa , K. , Akiyama , F. , Kasumi , F. , Sakamoto , G. and Nakamura , Y.Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer . Cancer Res. , 50 , 7184 – 7189 ( 1990. ). [PubMed] [Google Scholar]
- 21. ) Steeg , P. S. , Bevilacqua , G. , Kopper , L. , Thorgeirsson , U. P. , Talmadge , J. E. , Liotta , L. A. and Sobel , M. E.Evidence for a novel gene associated with low tumor metastatic potential . J. Natl. Cancer Inst. , 80 , 200 – 204 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 22. ) Varesco , L. , Caligo , M. A. , Simi , P. , Black , D. M. , Nardini , V. , Casarino , L. , Rocchi , M. , Ferrara , G. , Solomon , E. and Bevilacqua , G.The NM23 gene maps to human chromosome band 17q22 and shows a restriction fragment length polymorphism with Bg/II . Genes Chromosomes Cancer , 4 , 84 – 88 ( 1992. ). [DOI] [PubMed] [Google Scholar]
- 23. ) Hall , J. M. , Lee , M. K. , Newman , B. , Morrow , J. E. , Anderson , L. A. , Huey , B. and King , M‐C.Linkage of early‐onset familial breast cancer to chromosome 17q21 . Science , 250 , 1684 – 1689 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 24. ) Sato , T. , Saito , H. , Swensen , J. , Olifant , A. , Wood , C. , Danner , D. , Sakamoto , T. , Takita , K. , Kasumi , F. , Miki , Y. , Skolnick , M. and Nakamura , Y.The human prohibition gene located on chromosome 17q21 is mutated in sporadic breast cancer . Cancer Res. , 52 , 1643 – 1646 ( 1992. ). [PubMed] [Google Scholar]